News Focus
News Focus
Followers 480
Posts 61846
Boards Moderated 15
Alias Born 09/20/2001

Re: kevli33 post# 185895

Thursday, 03/21/2019 10:55:09 AM

Thursday, March 21, 2019 10:55:09 AM

Post# of 519116
Launched two days ago - Ereshefsky's been working on it for almost a year:


Chief Scientific Officer - Early Phase
Company NameCollaborative Neuroscience Network, LLC.
Dates Employed May 2018 – Present
Employment Duration 11 mos
Location So. CAl
Have conducted 200+ early phase trials in CNS, medical, Asian bridging, and HNV populations including FiH SAD/MAD, DDI, BA/BE, 505b2, and POCs. Have expertise in designing and conducting studies incorporating experimental medicine strategies, as well as translational drug development tools supporting neurocircuitry/biomarker based (RDoC) strategies, i.e., continuous CSF sampling, QEEG, ERP, PSG, sMRI, fMRI, PET, and cognitive and behavioral paradigms.



https://www.linkedin.com/in/ereshefskyfollowthemolecule/

I think Biogen and Eaisai are out of the loop.



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News